¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 4) : 2022-04-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 4) : 2022-04-02
±³À°ÀÏÀÚ : 2022-04-02
±³À°Àå¼Ò : (¿Â, ¿ÀÇÁ¶óÀÎ º´Çà) ¿ÀÇÁ¶óÀÎ Àå¼Ò: ¼­¿ï ÄÚ¿¢½º  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) APASL 2022 (DAY 4)
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : APASL 2022 Áغñ»ç¹«±¹
¿¬¶ôó : 02-707-0091  
À̸ÞÀÏ : apasl2022@insession.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 32 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 800,000¿ø      
ºñ°í Category Early Bird Rate Regular Rate Onsite Rate December 31(Fri), 2021 February 20(Sun), 2022 Off-line Virtual Off-line Virtual Off-line VirtualAPASL Member USD 300 USD200 USD400 USD300 USD 500 USD 400Non APASL Member USD 500 USD 300 USD 600 USD 400 USD 700 USD 500Trainee/Resident/Nurse USD 200 USD 100 USD 300 USD 200 USD 400 USD 300Accompanying Person USD 150 - USD 200 - USD 300 -Industry Partner USD 600 USD 600 USD 700 USD 700 USD 800 USD 800 / *»çÀüµî·Ï2022³â 2¿ù 20ÀÏ(ÀÏ)±îÁö [ÇöÀå] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 15¸¸¿ø, µ¿¹ÝÀÚ 15¸¸¿ø, Industry Partner 70¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 25¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 12¸¸¿ø, Industry Partner 70¸¸¿ø, *ÇöÀåµî·Ï [ÇöÀå] Àü¹®ÀÇ 35¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 18¸¸¿ø, µ¿¹ÝÀÚ 18¸¸¿ø, Industry Partner 80¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç 15¸¸¿ø, Industry Partner 80¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-02 101+102, 1F 10:30~10:50 HBV  Teerha Piratvisuth(Songklanagarind Hospital, Prince of Songkla University) 
±³À°½Ã°£ 04-02 101+102, 1F 10:50~11:10 HCV  Naoya Sakamoto(Hokkaido University Graduate School of Medicine) 
±³À°½Ã°£ 04-02 101+102, 1F 11:10~11:30 NAFLD  Jung Il Lee(Yonsei University College of Medicine) 
±³À°½Ã°£ 04-02 101+102, 1F 11:30~11:50 HCC  Ann-Lii Cheng(National Taiwan University Cancer Center) 
Åä·Ð 04-02 101+102, 1F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 04-02 101+102, 1F 13:30~13:50 ACLF  Dong Joon Kim(Hallym University College of Medicine) 
±³À°½Ã°£ 04-02 101+102, 1F 13:50~14:10 MAFLD  Jacob George(University of Sydney) 
±³À°½Ã°£ 04-02 101+102, 1F 14:10~14:30 Diagnosis and monitoring of portal hypertension  Xiaolong Qi(The First Hospital of Lanzhou University) 
±³À°½Ã°£ 04-02 101+102, 1F 14:30~14:50 COVID-19 and liver  Grace LH Wong(Faculty of Medicine, The Chinese University of Hong Kong) 
Åä·Ð 04-02 101+102, 1F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 04-02 101+102, 1F 16:00~16:30 Perspectives of ACLF in the East  Ashok Choudhury(Institute of Liver and Biliary Sciences) 
±³À°½Ã°£ 04-02 101+102, 1F 16:30~17:00 Perspectives of ACLF in the West  Rajiv Jalan(University College London Medical School, Royal Free Hospital) 
Åä·Ð 04-02 101+102, 1F 17:00~17:30 Round table discussion  Paulo Angeli, Dong Joon Kim, Suthat Liangpunsakul() 
±³À°½Ã°£ 04-02 201+202, 2F 10:30~10:50 Evaluation and management of renal dysfunction in liver cirrhosis  Florence Wong(Toronto General Hospital) 
±³À°½Ã°£ 04-02 201+202, 2F 10:50~11:10 Revisiting the role of albumin in liver cirrhosis  Han-Chieh Lin(Taipei Veterans General Hospital) 
±³À°½Ã°£ 04-02 201+202, 2F 11:10~11:30 Optimal timing of endoscopy and TIPS in variceal bleeding  Sung Won Lee(College of Medicine, The Catholic University of Korea) 
±³À°½Ã°£ 04-02 201+202, 2F 11:30~11:50 Advances in therapeutic options for portal hypertension  Jordi Gracia-Sancho(IDIBAPS Biomedical Research Institute) 
Åä·Ð 04-02 201+202, 2F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 04-02 201+202, 2F 13:30~13:50 How to evaluate sarcopenia in cirrhosis  En Young Jo(Wonkwang University School of Medicine) 
±³À°½Ã°£ 04-02 201+202, 2F 13:50~14:10 Interaction between muscle wasting and progression of liver disease  Anil C Anand(Kalinga Institute of Medical Sciences) 
±³À°½Ã°£ 04-02 201+202, 2F 14:10~14:30 Epidemiology and prognosis in cirrhosis accompanying sarcopenia  Puneeta Tandon(University of Alberta) 
±³À°½Ã°£ 04-02 201+202, 2F 14:30~14:50 The way to care and treat sarcopenia  Jeong Han Kim(Konkuk University School of Medicine) 
Åä·Ð 04-02 201+202, 2F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 04-02 201+202, 2F 16:00~16:20 Recent advances in the mechanism of liver fibrosis  Norifumi Kawada(Graduate School of Medicine, Osaka City University) 
±³À°½Ã°£ 04-02 201+202, 2F 16:20~16:40 Fibrosis reversal and regeneration of the liver  Ashish Kumar(Sir Ganga Ram Hospital) 
±³À°½Ã°£ 04-02 201+202, 2F 16:40~17:00 The role of lympatic system in cirrhotic complications  Yasuko Iwakiri(Yale University School of Medicine) 
±³À°½Ã°£ 04-02 201+202, 2F 17:00~17:20 The gut-liver axis in fibrosis and PHT  Soung Won Jeong(Soonchunhyang University College of Medicine) 
Åä·Ð 04-02 201+202, 2F 17:20~17:30 Discussion  () 
±³À°½Ã°£ 04-02 203, 2F 10:30~10:50 Management of HBV in immunocompromised patients  Su Jong Yu(Seoul National University College of Medicine) 
±³À°½Ã°£ 04-02 203, 2F 10:50~11:10 Co-infection of HBV and HCV  Chun-Jen Liu(National Taiwan University College of Medicine and Hospital) 
±³À°½Ã°£ 04-02 203, 2F 11:10~11:30 HBV and HCV in pregnancy  Ki Tae Yoon(Pusan National University School of Medicine) 
±³À°½Ã°£ 04-02 203, 2F 11:30~11:50 Updates on HEV infection  Anil C Anand(Kalinga Institute of Medical Sciences) 
Åä·Ð 04-02 203, 2F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 04-02 203, 2F 13:30~13:50 From NAFLD to MAFLD  Jian-Gao Fan(Shanghai Jiao Tong University School of Medicine) 
±³À°½Ã°£ 04-02 203, 2F 13:50~14:10 NAFLD and diabetes mellitus  Toshinari Takamura(Kanazawa University Graduate School of Medical Sciences) 
±³À°½Ã°£ 04-02 203, 2F 14:10~14:30 NAFLD and thyroid dysfunction  Paul M. Yen(Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School) 
±³À°½Ã°£ 04-02 203, 2F 14:30~14:50 Muscle alterations in NAFLD  Min Kyu Kang(Yeungnam University College of Medicine) 
Åä·Ð 04-02 203, 2F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 04-02 203, 2F 16:00~16:20 The role and unmet needs of HCC immunotherapy  Thomas Yau(The University of Hong Kong) 
±³À°½Ã°£ 04-02 203, 2F 16:20~16:40 Immune profiling for effector and suppressive T cells in tumor immune microenvironment  Sang-Jun Ha(Yonsei University College of Life Science and Biotechnology) 
±³À°½Ã°£ 04-02 203, 2F 16:40~17:00 Cell immunotherapy for HCC: Chimeric antigen receptor cell  Mitchell Ho(National Cancer Institute) 
±³À°½Ã°£ 04-02 203, 2F 17:00~17:20 Biomarkers in HCC immunotheraphy  Valerie Chew(SingHealth-DukeNUS Academic Medical Centre) 
Åä·Ð 04-02 203, 2F 17:20~17:30 Discussion  () 
±³À°½Ã°£ 04-02 205A, 2F 08:00~08:20 Morbidly obese and diabetic NASH without cirrhosis: Pharmacotherapy first  Jian-Gao Fan(Shanghai Jiao Tong University School of Medicine) 
±³À°½Ã°£ 04-02 205A, 2F 08:20~08:40 Morbidly obese and diabetic NASH without cirrhosis: Bariatric surgery first  George Boon-Bee Goh(Singapore General Hospital) 
Åä·Ð 04-02 205A, 2F 08:40~09:00 Discussion  () 
±³À°½Ã°£ 04-02 205B, 2F 08:00~08:20 Hepatorenal syndrome  Byung Seok Kim(Catholic University of Daegu College of Medicine) 
±³À°½Ã°£ 04-02 205B, 2F 08:20~08:40 Hepatopulmonary syndrome  Mi Na Kim(CHA University) 
Åä·Ð 04-02 205B, 2F 08:40~09:00 Discussion  () 
±³À°½Ã°£ 04-02 205B, 2F 10:30~10:50 Interpreting liver function tests  Nae-Yun Heo(Inje University College of Medicine) 
±³À°½Ã°£ 04-02 205B, 2F 10:50~11:10 Safe use of analgesics in patients with chronic liver disease  Minjong Lee(Ewha Womans University College of Medicine) 
±³À°½Ã°£ 04-02 205B, 2F 11:10~11:30 Treatment of NAFLD with diet and exercise: Motivating patients  Yuri Cho(Research Institute and Hospital, National Cancer Center) 
±³À°½Ã°£ 04-02 205B, 2F 11:30~11:50 Management of adverse events in patients receiving TKIs or ICIs  Hye Won Lee(Yonsei University College of Medicine) 
Åä·Ð 04-02 205B, 2F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 04-02 205B, 2F 13:30~13:50 Hepatitis B virus: Toward a functional cure  Jihyun An(Hanyang University College of Medicine) 
±³À°½Ã°£ 04-02 205B, 2F 13:50~14:10 Hepatitis C virus: Is it now easy to cure?  Seong Kyun Na(Jeju National University College of Medicine) 
±³À°½Ã°£ 04-02 205B, 2F 14:10~14:30 Non-alcoholic fatty liver disease vs metabolic associated fatty liver disease  Jung Gil Park(Yeungnam University College of Medicine) 
±³À°½Ã°£ 04-02 205B, 2F 14:30~14:50 Nutrition in chronic liver disease  Kwang Il Seo(Kosin University College of Medicine) 
Åä·Ð 04-02 205B, 2F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 04-02 205B, 2F 16:00~16:20 Acute variceal bleeding in liver cirrhosis  Chang Hun Lee(Chonbuk National University Medical School) 
±³À°½Ã°£ 04-02 205B, 2F 16:20~16:40 Acute kidney injury in liver cirrhosis  Myeong Jun Song(College of Medicine, The Catholic University of Korea) 
±³À°½Ã°£ 04-02 205B, 2F 16:40~17:00 Management of acute-on-chronic liver failure  Seong Hee Kang(Yonsei University Wonju College of Medicine) 
±³À°½Ã°£ 04-02 205B, 2F 17:00~17:20 A recent update on systemic therapy for advanced HCC  Sung-Bum Cho(Chonnam National University Medical School) 
Åä·Ð 04-02 205B, 2F 17:20~17:30 Discussion  () 
±³À°½Ã°£ 04-02 209A, 2F 08:00~08:20 Difficult-to-treat early-stage HCC  Ju Hyun Shim(University of Ulsan College of Medicine) 
±³À°½Ã°£ 04-02 209A, 2F 08:20~08:40 Intermediate-stage HCC beyond up-to-seven criteria  Naoshi Nishida(Faculty of Medicine, Kindai University) 
±³À°½Ã°£ 04-02 209A, 2F 08:40~09:00 HCC in patients with Child-Pugh class B  Bo Hyun Kim(National Cancer Center) 
±³À°½Ã°£ 04-02 209B, 2F 08:00~08:20 Dysbiosis in chronic liver disease  Do Seon Song(College of Medicine, The Catholic University of Korea) 
±³À°½Ã°£ 04-02 209B, 2F 08:20~08:40 Modulation of gut microbiota  Hong Koh(Yonsei University College of Medicine) 
Åä·Ð 04-02 209B, 2F 08:40~09:00 Discussion  () 
±³À°½Ã°£ 04-02 209AB, 2F 10:30~10:50 Epidemiology of intrahepatic cholangiocarcinoma in Korea  Mee Joo Kang(National Cancer Center) 
±³À°½Ã°£ 04-02 209AB, 2F 10:50~11:10 The efficacy of lymph node dissection for intrahepatic cholangiocarcinoma  Tomohiko Adachi(Nagasaki University Graduate School of Biomedical Sciences) 
±³À°½Ã°£ 04-02 209AB, 2F 11:10~11:30 Present and future of chemotherapy for intrahepatic cholangiocarcinoma; Adjuvant, neoadjuvant and palliative  Hei-Cheul Jeung(Yonsei University College of Medicine) 
±³À°½Ã°£ 04-02 209AB, 2F 11:30~11:50 Optimal treatment for recurrent intrahepatic cholangiocarcinoma: when do we do surgery?  Yuzo Umeda(Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences) 
Åä·Ð 04-02 209AB, 2F 11:50~12:00 Discussion  () 
±³À°½Ã°£ 04-02 209AB, 2F 13:30~13:50 Surveillance for HCC recurrence after surgical resection  Dong Hwan Jung(University of Ulsan College of Medicine) 
±³À°½Ã°£ 04-02 209AB, 2F 13:50~14:10 Currently available non-operative treatment option for recurrent HCC after surgical resection  Sun Young Yim(Korea University College of Medicine) 
±³À°½Ã°£ 04-02 209AB, 2F 14:10~14:30 Indication and prognosis of repeat liver resection for recurrent HCC *Pre-recorded Lecture  Toru Ikegami(The Jikei University School of Medicine) 
±³À°½Ã°£ 04-02 209AB, 2F 14:30~14:50 When to consider liver transplantation in hepatocellular carcinoma patients?  Shu-sen Zheng(Zhejiang University School of Medicine) 
Åä·Ð 04-02 209AB, 2F 14:50~15:00 Discussion  () 
±³À°½Ã°£ 04-02 209AB, 2F 16:00~16:15 Current role and limitations of laparoscopic liver resection for hepatocellular carcinoma  Tan To Cheung(Queen Mary Hospital, The University of Hong Kong) 
±³À°½Ã°£ 04-02 209AB, 2F 16:15~16:30 Is laparoscopic liver resection really beneficial in salvage liver transplantation for hepatocellular carcinoma?  Olivier Scatton(Sorbonne University, INSERM) 
±³À°½Ã°£ 04-02 209AB, 2F 16:30~16:45 Laparoscopic repeated hepatectomy for recurrent hepatocellular carcinoma  Young Seok Han(Kyungpook National University College of Medicine) 
±³À°½Ã°£ 04-02 209AB, 2F 16:45~17:00 How to dissect liver parenchyma along the intersegmental plane in the patient with cirrhosis  Yuta Abe(Keio University School of Medicine) 
±³À°½Ã°£ 04-02 209AB, 2F 17:00~17:15 Parenchymal sparing anatomical liver resection for hepatocellular carcinoma: Preoperative 3D simulation and intraoperative ICG navigation  Ji Hoon Kim(National Cancer Center) 
Åä·Ð 04-02 209AB, 2F 17:15~17:30 Discussion  () 
±³À°½Ã°£ 04-02 Auditorium, 3F 09:00~09:15 Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD  Liang-Jie Tang(The First Affiliated Hospital of Wenzhou Medical University) 
±³À°½Ã°£ 04-02 Auditorium, 3F 09:15~09:30 The dynamics of Hepato-Cardiac axis : A Case-control study of Left Ventricular Diastolic Dysfunction in liver cirrhosis  Rushil Solanki(GOVERNMENT MEDICAL COLLEGE TRIVANDRUM) 
±³À°½Ã°£ 04-02 Auditorium, 3F 09:30~09:45 Association between statin use and risk of hepatocellular carcinoma recurrence following liver resection: A nationwide cohort study  Won-Mook Choi(University of Ulsan College of Medicine Asan Medical Center) 
±³À°½Ã°£ 04-02 Auditorium, 3F 09:45~10:00 TBD  TBD() 
±³À°½Ã°£ 04-02 Auditorium, 3F 10:30~11:00 Precision medicine for prediction of prognosis in liver disease  Ray W Kim(Stanford University Medical Center) 
±³À°½Ã°£ 04-02 Auditorium, 3F 11:00~11:30 Long journey of the APASL  Masao Omata(Yamanashi Central and Kita Hospitals, The University of Tokyo) 
±³À°½Ã°£ 04-02 Auditorium, 3F 11:30~12:00 Changing epidemiology of liver disease in Asia-Pacific region  Tawesak Tanwandee(Siriraj Hospital, Mahidol University) 
±³À°½Ã°£ 04-02 Auditorium, 3F 13:30~14:00 Management of HCC in Asia  Pierce Chow(Singapore General Hospital, Duke-NUS) 
±³À°½Ã°£ 04-02 Auditorium, 3F 14:00~14:30 Locoregional therapy for HCC  Shuichiro Shiina(Juntendo University) 
±³À°½Ã°£ 04-02 Auditorium, 3F 14:30~15:00 Teatment for advanced HCC  Pei-Jer Chen(National Taiwan University Hospital) 
±³À°½Ã°£ 04-02 Auditorium, 3F 16:00~16:30 HCV: From discovery to cure and beyond  Raymond T Chung(Harvard Medical School) 
±³À°½Ã°£ 04-02 Auditorium, 3F 16:30~17:00 NAFLD: Updates from bench to clinic  David E. Cohen(Brigham and Womens Hospital) 
±³À°½Ã°£ 04-02 Auditorium, 3F 17:00~17:30 Liver transplantation: Achievements and future challenges  Kyung-Suk Suh(Seoul National University College of Medicine) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 4) : 2022-04-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦64Â÷ ´ëÇÑÀÌ°úÇÐȸ Çмú´ëȸ/2022 ÀÌ°ú ¼ú±â¿Í °Ë»çÀÇ Æǵ¶(2ÀÏÂ÷) : 2022-04-03
´ÙÀ½±Û ´ëÇѳ²¼º°úÇÐȸ The 6th International Joint Meeting of Pan-Asian Men's Health Forum and 39th Annual Meeting of KSSMA in 2022 : 2022-04-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21212 °æ±â Á¦18ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú ½ÉÆ÷Áö¾ö : 2024-08-31 0 22 2024-07-02
21211 Àü³² 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãß°è Microsurgery Workshop : 2024-08-31 0 26 2024-07-02
21210 ¼­¿ï ´ëÇѽŻý¾ÆÇÐȸ Á¦15Â÷ ±³À°¼¼¹Ì³ª : 2024-08-30 0 18 2024-07-02
21209 ´ë±¸ ´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À° : 2024-08-27 0 24 2024-07-02
21208 ¼­¿ï 2024³âµµ ´ëÇÑÅëÁõÇÐȸ ¾à¹°Ä¡·á ¿¬¼ö°­Á : 2024-08-25 0 12 2024-07-02
21207 ¼­¿ï °³¿ø 18Áֳ⠱â³ä 2024 °­µ¿°æÈñ´ëÇб³º´¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-08-25 0 14 2024-07-02
21206 ¼­¿ï ´ëÇÑÃÊÀ½ÆÄÀÇÇÐȸ º¹ºÎ& ºñ´¢ ÃÊÀ½ÆÄ °Ë»ç ÀÔ¹®±³À°: °­ÀÇ ¹× ½Ç½À : 2024-08-25 0 13 2024-07-02
21205 ´ë±¸ Á¦3ȸ °è¸í´ëÇб³ µ¿»êº´¿ø ³»°ú ¿¬¼ö°­Á : 2024-08-25 0 16 2024-07-02
21204 °æºÏ Çѱ¹Ãµ½Ä¾Ë·¹¸£±âÇùȸ 2024 Post Graduate Asthma School (2ÀÏÂ÷) : 2024-08-25 0 14 2024-07-02
21203 ¼­¿ï Á¦32ȸ ´ëÇѺñ¸¸°Ç°­ÇÐȸ 2024 Ãß°èÇмú´ëȸ : 2024-08-25 0 14 2024-07-02
21202 ¼­¿ï Á¦14ȸ ¼Ò¾Æ°úÇб³½Ç ¼Ò¾Æ¾Ë·¹¸£±â, È£Èí±âÁúȯ ¿¬¼ö°­Á : 2024-08-25 0 10 2024-07-02
21201 ¼­¿ï ÇѾç´ëÇб³±¸¸®º´¿ø ¼Ò¾Æû¼Ò³â°ú ½Å»ý¾Æ, ¿µÀ¯¾Æ Why & How : 2024-08-24 0 12 2024-07-02
21200 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø º¸¼ö±³À° : 2024-08-24 0 9 2024-07-02
21199 ¼­¿ï ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ Á¦ 8ȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó : 2024-08-24 0 11 2024-07-02
21198 ¼­¿ï 2024³â ´ëÇѳ»ºÐºñÇÐȸ ´ëÇѼºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-08-24 0 16 2024-07-02
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷